The association of metabolic syndrome with atrial fibrillation: An emerging epidemiological and pathophysiological hypothesis

Cardiology

Volumn 104, Issue 3, 2005, Pages 148-149

  Korantzopoulos, Panagiotis ^a   Kokkoris, Stelios ^b   Papaioannides, Demetrios ^c  

^a G HATZIKOSTA GENERAL HOSPITAL   (Greece)

^b TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^c Psychiatric Hospital of Attika Dafni   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; HEALTH CARE ORGANIZATION; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; MEDICAL RESEARCH; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ATRIAL FIBRILLATION; EPIDEMIOLOGIC STUDIES; HUMANS; HYPERTENSION; INCIDENCE; METABOLIC SYNDROME X; UNITED STATES;

EID: 24744470023     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087636     Document Type: Letter

References (14)

1. Tsang TSM, Gersh BJ: Atrial fibrillation: an old disease, a new epidemic. Am J Med 2002; 113:432-435.
2. Korantzopoulos P, Kolettis TM, Goudevenos JA, Siogas K: Errors and pitfalls in the non-invasive management of atrial fibrillation. Int J Cardiol 2005; in press.
3. Allessie M, Ausma J, Schotten U: Electrical, contracticle and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54: 230-246.
4. Scott CL: Diagnosis, prevention, and intervention for the metabolic syndrome. Am J Cardiol 2003;92(suppl):35i-42i.
5. Miranda PJ, DeFronzo RA, Califf RM, Guyton JR: Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J 2005;149:33-45.
6. Korantzopoulos P, Kolettis TM, Goudevenos J: Atrial fibrillation in hypertension: an established association with several unresolved issues. Cardiology 2003;100:105-106.
7. Kannel WB, Wolf PA, Benjamin EJ, Levy D: Prevalence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N-9N.
8. Ostgren CJ, Merlo J, Rastam L, Lindbland U, for Skaraborg Hypertension and Diabetes Project: Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diabetes Obes Metab 2004;6:367-374.
9. Wang TJ, Parise H, Levy D, D'Agostino RB, Wolf PA, Vasan RS, Benjamin EJ: Obesity and the risk of new-onset atrial fibrillation. JAMA 2004;292:2471-2477.
10. Coromilas J: Obesity and atrial fibrillation. Is one epidemic feeding the other? JAMA 2004; 292:2519-2520.
11. Ceriello A, Motz E: Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004;24:816-823.
12. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-1761.
13. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson PW: C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004;110:380-385.
14. Korantzopoulos P, Kolettis T, Siogas K, Goudevenos J: Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit 2003;9: RA225-RA229.